whighlander
Senior Member
- Joined
- Aug 14, 2006
- Messages
- 7,812
- Reaction score
- 647
Re: Novartis Expansion
DZH -- as Stel pointed out -- the cuts are mostly sales people connected with drugs coming off patent -- if anything it just impels Novartis to build more in Cambridge
Cambridge is all about drugs which so far exist only as concepts and that Novartis hopes will come under patent in about 3 to 5 years and which they will start selling in 2020 and by 2025 they will be making B$s before they too come off patent in the 2030 time frame
I feel like this certainly might have an effect on expansion...
http://money.cnn.com/2012/01/13/news/companies/novartis_jobs/
Also, there was a recent voluntary recall on Excedrin, and correct me if I'm wrong, but isn't too a Novartis drug?
DZH -- as Stel pointed out -- the cuts are mostly sales people connected with drugs coming off patent -- if anything it just impels Novartis to build more in Cambridge
Cambridge is all about drugs which so far exist only as concepts and that Novartis hopes will come under patent in about 3 to 5 years and which they will start selling in 2020 and by 2025 they will be making B$s before they too come off patent in the 2030 time frame